|
Volumn 15, Issue 1, 2009, Pages 13-15
|
The effect of a novel cytokine, high mobility group box 1 protein, on the development of traumatic sepsis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
BACTERIAL DNA;
CHINESE DRUG;
EXOTOXIN;
HIGH MOBILITY GROUP B1 PROTEIN;
HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY;
INTERLEUKIN 1 BETA ANTAGONIST;
INTERLEUKIN 1BETA;
LIPOPOLYSACCHARIDE;
MESSENGER RNA;
RECOMBINANT BACTERICIDAL PERMEABILITY INCREASING PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
UNCLASSIFIED DRUG;
XUEBIJING;
ARTICLE;
BURN;
CD3+ T LYMPHOCYTE;
CELLULAR IMMUNITY;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
DRUG EFFICACY;
DRUG MECHANISM;
GENE EXPRESSION REGULATION;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HEMORRHAGIC SHOCK;
HUMAN;
IMMUNE DEFICIENCY;
LYMPHOCYTE PROLIFERATION;
MORTALITY;
MULTIPLE ORGAN FAILURE;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN EXPRESSION;
RECOMMENDED DRUG DOSE;
SEPSIS;
SEPTIC SHOCK;
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;
T LYMPHOCYTE;
THERMAL INJURY;
UPREGULATION;
CYTOKINES;
DRUGS, CHINESE HERBAL;
HMGB1 PROTEIN;
HUMANS;
IMMUNITY, CELLULAR;
INFLAMMATION MEDIATORS;
SEPSIS;
WOUNDS AND INJURIES;
|
EID: 60849120444
PISSN: 16720415
EISSN: None
Source Type: Journal
DOI: 10.1007/s11655-009-0013-0 Document Type: Article |
Times cited : (14)
|
References (0)
|